Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hormone replacement therapy - less is often more].

H P Schneider1

  • 1Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Münster. HPG.Schneider@uni.muenster.de

Zentralblatt Fur Gynakologie
|December 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The World Veterinary Association and animal welfare.

Revue scientifique et technique (International Office of Epizootics)·2005
Same author

[Reliability of the Menopause Rating Scale (MRS): Investigation in the German population].

Zentralblatt fur Gynakologie·2002
Same author

The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36.

Climacteric : the journal of the International Menopause Society·2002
Same author

The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints.

Climacteric : the journal of the International Menopause Society·2002
Same author

The role of antiandrogens in hormone replacement therapy.

Climacteric : the journal of the International Menopause Society·2001
Same author

Application and factor analysis of the menopause rating scale [MRS] in a post-marketing surveillance study of Climen.

Maturitas·2001
Same journal

About 150 births naturally after previous Caesarean section.

Zentralblatt fur Gynakologie·2010
Same journal

About lutein cysts found in hydrops foetus et placentae.

Zentralblatt fur Gynakologie·2010
Same journal

The potencies of the burner epithelium, especially a tendency to form serous epitrel, squamous and mucosal epithelium.

Zentralblatt fur Gynakologie·2010
Same journal

Two double birth defects causing obstetric difficulties.

Zentralblatt fur Gynakologie·2010
Same journal

The uterine size and fundus level in the first part of pregnancy.

Zentralblatt fur Gynakologie·2010
Same journal

The crossbar interposition.

Zentralblatt fur Gynakologie·2010
See all related articles

Postmenopausal women often decline Hormone Therapy (HRT) due to side effects and cancer fears. Low-dose transdermal HRT may mitigate these risks, improving acceptance and adherence for symptom management and prevention.

Area of Science:

  • Reproductive endocrinology
  • Menopause management
  • Pharmacology

Context:

  • Postmenopausal women's declining acceptance of Hormone Therapy (HRT) for symptom management and prevention.
  • Common reasons for HRT non-acceptance include bleeding issues, breast tenderness, weight gain, and cancer concerns.
  • Need for alternative HRT delivery methods to improve tolerability and adherence.

Purpose:

  • To explore the challenges in long-term Hormone Therapy acceptance among symptomatic postmenopausal women.
  • To identify key factors influencing HRT non-compliance, such as adverse effects and safety perceptions.
  • To evaluate the potential of low-dose transdermal Hormone Therapy in mitigating risks and enhancing patient acceptance.

Summary:

  • Symptomatic postmenopausal women frequently discontinue Hormone Therapy (HRT) due to adverse effects and fear of cancer, limiting its preventive potential.

Related Experiment Videos

  • Bleeding problems, breast tenderness, weight gain, and cancer anxiety are primary barriers to HRT adherence.
  • Clinical experience suggests low-dose transdermal HRT application may significantly reduce risks, potentially improving patient acceptance.

    • Impact:

    • Improved understanding of patient-reported barriers to HRT use.
    • Highlights the potential of transdermal delivery systems for safer and more acceptable HRT.
    • Suggests a strategy to enhance HRT adherence for managing menopausal symptoms and long-term health.
    • Potential for increased utilization of HRT for both symptom relief and preventive health benefits in postmenopausal women.